The University of Chicago Header Logo

Connection

Lixing Yang to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Lixing Yang has written about Xenograft Model Antitumor Assays.
Lixing Yang
Connection Strength
0.303
Xenograft Model Antitumor Assays
  1. Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors. Clin Cancer Res. 2024 Dec 02; 30(23):5445-5458.
    View in: PubMed
    Score: 0.195
  2. Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing. Am J Hum Genet. 2016 05 05; 98(5):843-856.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.